• Latest Posts

European Cancer Deals Increasingly Focus on Natural Killer Cells

Covid-19 Leaves Lasting Impact on Hematology at ASH 2020 Conference

Kiadis’ Natural Killer Cell Therapies Earn €308M Acquisition by Sanofi

Sanofi Enlists Cell Therapy Firm Kiadis in €875M Immuno-Oncology Deal

Mass Layoffs as Dutch Biotech Cancels Phase III Cell Therapy Trial

Dutch Company Raises €28M to Push Cancer Cell Therapy to European Market

In Depth 23 Jan 2018

Walking with the Dinosaurs of European Biotech: Which of Them is Roaring the Loudest?

Dutch Bone Marrow Transplant for Blood Cancer could get rid of Donor Matching

Dutch Biotech Gets Special Designation for Reduced Risk Blood Cancer Treatment

Interview 22 May 2017

Meet the New CEO of the Dutch Biotech Making a Cure for Blood Cancer

BRIEF: Dutch Biotech Goes for MAA in the EU with new Immunotherapy

Curing Cancer with Safer Transplants: UK Approval to start Clinical Trials